Abstract: Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Abstract: Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Abstract: Low profile, self-expandable, blood flow restrictors include a hollow channel open at axial ends to allow blood flow through the restrictor installed in a blood vessel. The channel may include a mesh and have a narrowing, or sandglass, profile to reduce blood flow. The sandglass shape is in a central portion of the channel and may be surrounded by a blocking coating impermeable to blood flow or a suture that dissolves over time. The mesh may be formed of a memory alloy. Restrictors include a retrieval connector at an end that is permeable to blood flow and permits attachment for restrictor positioning with a catheter.

Abstract: A low profile, self-expandable, blood flow resisting device comprising: a tubular channel being a hollow channel with open axial ends configured to allow passage of fluids, said tubular channel being a mesh channel, said tubular channel having a sandglass profiled, characterised in that, a pre-defined intermittent portion across axial orientation of said tubular channel being relatively and substantially narrower in width, said tubular channel being made of a shape memory alloy; a retrieval mechanism advantageously located at an operative proximal end of said device.

Abstract: Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Abstract: Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Abstract: Provided herein are methods for treating, preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Abstract: The present invention relates to method for inducing bronchodilation in a patient in need thereof comprising (a) providing at least one dose of an inhalation mixture comprising a ?2 agonist to said patient; and (b) delivering said inhalation mixture with an inhalation nebulizer, as well as dosage formulations comprising a ?2 agonist.

Abstract: The present invention relates to unit dose formulations comprising an inhalable albuterol solution, wherein the inhalation albuterol solution is formulated with albuterol free base, a tonicity adjusting agent, a pH adjusting agent and water. Methods of preparing the unit dose formulation are also provided.